endomyocardial biopsy (EBM)-proven virus-negative myocarditis research hub

Myocarditis Therapy with IL-1 inhibitor (MYTH-1): a double-blind, phase IIa, placebo controlled, randomized clinical trial to evaluate the efficacy and safety of anakinra in addition to standard of care for the treatment of virus-negative myocarditis.

This study looks at a new treatment called anakinra for a heart condition called myocarditis. It aims to see if anakinra, given alongside usual care, can help improve heart function in adults whose myocarditis isn't caused by a virus.